Thalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and Tyler White are looking forward to an exciting few days at the Revolutionizing Atopic Dermatitis Conference (RAD 2026) in Nashville. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Our TRI team will be connecting with colleagues and partners across the dermatology and clinical research community.

We’re also excited to share our new EASI Rater Training program authored by Dr. Jonathan Silverberg (co-chair of RAD 2026) designed to support consistent and standardized EASI assessment in clinical trials.

If you’ll be attending RAD, feel free to reach out — we’d welcome the opportunity to connect!

And learn more about our library of trainings at www.thalocan.com/trainings/